PBK · Open position
Dermal Model to Understand Skin Wound Healing and Topical Drug Delivery
A multi-compartment dermal PBPK model that captures how a disrupted skin barrier changes drug absorption, local retention and systemic clearance as a wound heals.
- PBK
- BURNS
- CSM
- Supervisor
- V. S. Muniraj
- Host
- University of Amsterdam · AmsterdamUMC
- Level
- MSc
- Contact
- [email protected]
Read the full project description
Skin wound healing is a dynamic physiological process involving inflammation, tissue regeneration, matrix remodelling, and vascular restoration. When the skin barrier is damaged, the absorption, local retention, and systemic clearance of therapeutic drugs change dramatically compared to intact tissue.
Physiologically based pharmacokinetic (PBPK) modelling offers a mechanistic framework to simulate how drugs and signalling factors permeate damaged skin, interact with local tissue layers, and enter the systemic circulation [1, 2]. By combining skin anatomy, biophysical barrier disruption, and formulation science, this project aims to develop a predictive dermal PBPK model that captures the changing microenvironment of healing wounds to guide safer and more effective topical therapies [3].
Objectives
- Build a multi-compartment dermal PBPK framework that captures physical changes in wounded skin, such as stratum corneum loss, altered blood perfusion, exudate flow, and progressive barrier recovery over time.
- Integrate physicochemical properties with diffusion and partition equations across damaged epidermal and dermal layers to predict local drug exposure and systemic absorption.
- Calibrate and validate the model against published in vitro permeation testing (IVPT) and clinical wound-healing datasets, quantifying how wound depth and healing stages affect local therapeutic bioavailability.
References
- Duong, J., et al. "Characterizing local and systemic exposure to clobetasol propionate in healthy subjects and patients with atopic dermatitis." British Journal of Clinical Pharmacology (2025).
- Patel, N., et al. "Multi-phase multi-layer mechanistic dermal absorption (MPML MechDermA) model to predict local and systemic exposure of drug products applied on skin." CPT: Pharmacometrics & Systems Pharmacology (2022).
- Polak, S., et al. "Prediction of concentration–time profile and its inter-individual variability following dermal drug absorption." Journal of Pharmaceutical Sciences (2012).
Work environment
The student will work within an interdisciplinary environment alongside computational modellers, pharmacologists, and biomedical scientists at UvA and AmsterdamUMC. You will gain practical expertise in mechanistic modelling, quantitative pharmacology, and model-informed drug development (MIDD), contributing directly to computational tools that reduce reliance on animal testing and optimize wound care.
These descriptions are condensed summaries of the full project proposals and may contain minor errors or be superseded by later revisions. Please confirm the details with the supervisor before applying.